News Daily News Registry Study Supports Curbing Cholesterol Screening for Young Adults Because of Low Overall Risk Yael L. Maxwell May 15, 2017
News Daily News Tool May Help Select Patients for Endovascular Stroke Treatment Todd Neale May 15, 2017
News Daily News Rivaroxaban Appears to Protect Against MI in Older Men With A-fib, but Not in Women Todd Neale May 11, 2017
News Conference News EAS 2017 FOURIER in Focus: Costs, Patient Selection, Combination Therapy, and Safety Debated as Lipid Experts Digest the Data Yael L. Maxwell April 26, 2017
News Conference News ACC 2017 My Takeaways From ACC 2017: Even With a Sea Change, the Tide Takes Its Time Shelley Wood March 23, 2017
News Conference News ACC 2017 Replacing Aspirin With Low-Dose Rivaroxaban for Post-ACS Therapy Appears Safe Todd Neale March 18, 2017
News Conference News ACC 2017 Rivaroxaban Bests Aspirin for Preventing Recurrence of VTE: EINSTEIN CHOICE L.A. McKeown March 18, 2017
News Conference News ACC 2017 ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More Shelley Wood March 10, 2017
News Daily News The Long and Short of It: DAPT Duration Choice After Stenting Gets Help From New Score Todd Neale March 10, 2017
News Daily News Global Burden of Elevated Systolic Blood Pressure on the Rise Michael O'Riordan January 10, 2017
News Daily News Registry Hints Staged Intervention Reduces Mortality in STEMI Patients With Multivessel CAD, but Controversy Remains L.A. McKeown January 09, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular News and Features for 2016 Shelley Wood December 29, 2016
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for November 2016 Shelley Wood November 30, 2016
News Daily News New USPSTF Guidelines Recommend Statins in ‘Appropriately Selected’ Primary-Prevention Patients Michael O'Riordan November 13, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Conference News ESC 2016 Optimal Approach for BP Lowering Debated Amid New J-Curve Signals in Stable CAD Todd Neale September 09, 2016
News Conference News ESC 2016 Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say Michael O'Riordan August 27, 2016
News Industry News Armetheon Announces Positive Results of Pharmacokinetics Study of Tecarfarin versus Warfarin August 25, 2016
News Daily News Beta-Blockers Not Beneficial After PCI for Stable Angina Michael O'Riordan August 17, 2016